Rochdi Rais

Home
Authors
Posts by Rochdi Rais

2743 Posts

Rochdi Rais is the chief content officer and financial and legal writer at USA Herald. He has been writing about finance, law, cryptocurrency and U.S. politics for years with over +4000 articles published during his career.

America May 14, 2025

Biogen Sues Ex-Collaborator Over Rights to Drug Tech

Biogen Inc. has filed a lawsuit against its former partner, Neurimmune Holding AG, over the rights to a novel therapeutic…

By Rochdi Rais

America May 14, 2025

DOJ Bans Law Firms Suing the U.S.

In a move to strengthen ethical standards and reduce conflicts of interest, Deputy Attorney General Todd Blanche has issued a…

By Rochdi Rais

America May 14, 2025

Walmart Ordered to Pay $223M in Trade Secrets Case

In a major development in a long-running legal battle, an Arkansas federal jury has awarded Zest Labs Inc. nearly $223…

By Rochdi Rais

America May 14, 2025

Pot Payment Co. Demands Court to Enforce $1.3M Settlement

CC Technology Corp. (CCTC), a Boulder-based fintech company, is calling on a Nevada federal court to intervene in a legal…

By Rochdi Rais

America May 14, 2025

FINRA Fines Goldman $1.4M for Faulty CAT Data

Goldman Sachs & Co. LLC has agreed to pay $1.45 million to settle claims from the Financial Industry Regulatory Authority…

By Rochdi Rais

America May 14, 2025

9th Circuit: Asterisk Fails to Protect CVS in Sanitizer Case

The Ninth Circuit Court of Appeals heard oral arguments Tuesday in a case where a man is suing CVS Pharmacy,…

By Rochdi Rais

America May 14, 2025

Wells Fargo Appeals Class Cert. Over ‘Sham’ Hiring Claims

Wells Fargo has filed a petition with the Ninth Circuit Court of Appeals, seeking to overturn the class certification granted…

By Rochdi Rais

America May 14, 2025

Snapchat Denies Role in Fentanyl Overdose Deaths in New Lawsuit

Snap Inc. has filed a formal response to the claims made in a Snapchat fentanyl overdose deaths lawsuit brought by…

By Rochdi Rais

America May 14, 2025

GSK Makes Bold $2B Move on Liver Drug

Global biopharmaceutical leader GSK PLC has entered into a definitive agreement to acquire efimosfermin, a promising liver-disease treatment, from Boston…

By Rochdi Rais

America May 13, 2025

Gov’t Seeks 6-Month Sentence for IUOE Ex-Prez in DOL Forms Cas

Federal prosecutors have requested a six-month prison sentence for James Callahan, former president of the International Union of Operating Engineers…

By Rochdi Rais